Panobinostat as Pan-deacetylase Inhibitor for the Treatment of Pancreatic Cancer: Recent Progress and Future ProspectsAvineesh Singh, Harish Rajak, Vijay K. Patel et al.|Oncology and Therapy|2016Cited by 41
The Safety, Efficacy and Therapeutic Potential of Histone Deacetylase Inhibitors with Special Reference to Panobinostat in Gastrointestinal Tumors: A Review of Preclinical and Clinical StudiesAvineesh Singh, Harish Rajak, Preeti Patel et al.|Current Cancer Drug Targets|2018Cited by 25
Pharmacophore Based 3D-QSAR, Virtual Screening and Docking Studies on Novel Series of HDAC Inhibitors with Thiophen Linker as Anticancer AgentsPreeti Patel, Harish Rajak, Avineesh Singh et al.|Combinatorial Chemistry & High Throughput Screening|2016Cited by 22
The combination of histone deacetylase inhibitors and radiotherapy: a promising novel approach for cancer treatmentEkta Shirbhate, Harish Rajak, Preeti Patel et al.|Future Oncology|2020Cited by 21
Combretastatin A-4 based thiophene derivatives as antitumor agent: Development of structure activity correlation model using 3D-QSAR, pharmacophore and docking studiesVijay K. Patel, Harish Rajak, Ravichandran Veerasamy et al.|Future Journal of Pharmaceutical Sciences|2017Cited by 17